| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BJC.2015.100 |
| P8608 | Fatcat ID | release_bt5map5qobe47kcqs5qu7mqnsq |
| P932 | PMC publication ID | 4402450 |
| P698 | PubMed publication ID | 25867265 |
| P5875 | ResearchGate publication ID | 273945064 |
| P50 | author | Dan Falkenback | Q56600433 |
| Angelique Levert-Mignon | Q63378762 | ||
| David C. Whiteman | Q37837275 | ||
| P2093 | author name string | M L Thomas | |
| D A Brown | |||
| Y V Bobryshev | |||
| R V Lord | |||
| S N Breit | |||
| S J Lord | |||
| O M Fisher | |||
| K K M Lee-Ng | |||
| N K Botelho | |||
| P2860 | cites work | Index for rating diagnostic tests | Q39605675 |
| Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples | Q39639960 | ||
| Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss | Q39893717 | ||
| Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. | Q40056643 | ||
| Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis | Q40359911 | ||
| Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays | Q40420929 | ||
| The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome | Q40436424 | ||
| Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers | Q40568605 | ||
| The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. | Q40835101 | ||
| Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities | Q43515891 | ||
| Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? | Q43690125 | ||
| Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus | Q43883413 | ||
| Antibody-based approach to high-volume genotyping for MIC-1 polymorphism | Q44077970 | ||
| Refining esophageal cancer staging | Q47880243 | ||
| Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study | Q48874889 | ||
| Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. | Q50661717 | ||
| Screening and surveillance for Barrett's esophagus-an unresolved dilemma | Q50895346 | ||
| Barrett's esophagus | Q57742664 | ||
| Observer variation in the diagnosis of dysplasia in Barrett's esophagus | Q68267912 | ||
| MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma | Q73653083 | ||
| Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus | Q74262458 | ||
| MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation | Q77787092 | ||
| MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | Q24317134 | ||
| Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection | Q24814631 | ||
| Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction | Q27026253 | ||
| Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum | Q30452357 | ||
| Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer | Q33723662 | ||
| Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer | Q34099900 | ||
| American Gastroenterological Association medical position statement on the management of Barrett's esophagus | Q34168686 | ||
| Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 | ||
| Receiver Operating Characteristic Curves and Their Use in Radiology | Q34266471 | ||
| British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus | Q34380645 | ||
| Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review | Q34487254 | ||
| Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer | Q35006757 | ||
| American Gastroenterological Association technical review on the management of Barrett's esophagus | Q35673305 | ||
| Cigarette Smoking Increases Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium | Q35874758 | ||
| Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity | Q36100858 | ||
| Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. | Q36421073 | ||
| Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer | Q36481328 | ||
| Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design | Q36936929 | ||
| Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium | Q37297394 | ||
| The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis | Q37945514 | ||
| Identification and Clinical Implementation of Biomarkers for Barrett's Esophagus | Q37977778 | ||
| Screening for oesophageal cancer. | Q37995081 | ||
| The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1 | Q38115886 | ||
| Barrett's Esophagus: The American Perspective | Q38116716 | ||
| Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues | Q38416120 | ||
| Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. | Q39402566 | ||
| The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. | Q39492314 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 1384-1391 | |
| P577 | publication date | 2015-03-17 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma | |
| P478 | volume | 112 |
| Q58763391 | A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas |
| Q64099112 | Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis |
| Q92973308 | GDF-15 in solid vs non-solid treatment-naïve malignancies |
| Q37702121 | GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway |
| Q90133777 | Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases |
| Q51732278 | Growth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells |
| Q47660322 | miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression |
Search more.